Report Detail

Pharma & Healthcare Global Atorvastatin Calcium Market Growth 2019-2024

  • RnM3064507
  • |
  • 06 March, 2019
  • |
  • Global
  • |
  • 159 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Atorvastatin calcium is a pharmaceutical raw material in the production of atorvastatin calcium drug (trade name: Lipitor), which is a prescription medicine that lowers the LDL cholesterol and triglycerides in the blood and can raise HDL cholesterol as well. Atorvastatin calcium usually is white powder and whose CAS number is 134523-03-8.
Atorvastatin calcium refers to a pharmaceutical raw material in the production of atorvastatin calcium drug. It contains chemical synthesis type and biocatalysis type. The atorvastatin calcium industry is a concentrated group relatively, as production qualification of atorvastatin calcium is controlled by government.
India and China are the main consumption bases, and India holds 35.39% consumption share, and China holds 18.98% consumption share in 2015. They occupy 54.37% of the global consumption in total.

According to this study, over the next five years the Atorvastatin Calcium market will register a 7.0% CAGR in terms of revenue, the global market size will reach US$ 230 million by 2024, from US$ 160 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Atorvastatin Calcium business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Atorvastatin Calcium market by product type, application, key manufacturers and key regions and countries.

This study considers the Atorvastatin Calcium value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Chemical Synthesis
Biocatalysis
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Tablet (Including Dispersible Tablet and General Tablet)
Capsule
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
DSM Sinochem Pharmaceuticals
Cadila Pharmaceuticals
Sun Pharmaceutical Industries
Dr. Reddy’s
Morepen
Teva Pharmaceutical Industries
Apotex Pharmachem
Sandoz Inc
Mylan Pharmaceuticals Inc.
Kremers Urban Pharmaceuticals Inc.
ScieGen Pharmaceuticals, Inc.
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Atorvastatin Calcium consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Atorvastatin Calcium market by identifying its various subsegments.
Focuses on the key global Atorvastatin Calcium manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Atorvastatin Calcium with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Atorvastatin Calcium submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.


Table of Contents

    2019-2024 Global Atorvastatin Calcium Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Atorvastatin Calcium Consumption 2014-2024
        • 2.1.2 Atorvastatin Calcium Consumption CAGR by Region
      • 2.2 Atorvastatin Calcium Segment by Type
        • 2.2.1 Chemical Synthesis
        • 2.2.2 Biocatalysis
        • 2.2.3 Others
      • 2.3 Atorvastatin Calcium Consumption by Type
        • 2.3.1 Global Atorvastatin Calcium Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Atorvastatin Calcium Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Atorvastatin Calcium Sale Price by Type (2014-2019)
      • 2.4 Atorvastatin Calcium Segment by Application
        • 2.4.1 Tablet (Including Dispersible Tablet and General Tablet)
        • 2.4.2 Capsule
        • 2.4.3 Others
      • 2.5 Atorvastatin Calcium Consumption by Application
        • 2.5.1 Global Atorvastatin Calcium Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Atorvastatin Calcium Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Atorvastatin Calcium Sale Price by Application (2014-2019)

      3 Global Atorvastatin Calcium by Players

      • 3.1 Global Atorvastatin Calcium Sales Market Share by Players
        • 3.1.1 Global Atorvastatin Calcium Sales by Players (2017-2019)
        • 3.1.2 Global Atorvastatin Calcium Sales Market Share by Players (2017-2019)
      • 3.2 Global Atorvastatin Calcium Revenue Market Share by Players
        • 3.2.1 Global Atorvastatin Calcium Revenue by Players (2017-2019)
        • 3.2.2 Global Atorvastatin Calcium Revenue Market Share by Players (2017-2019)
      • 3.3 Global Atorvastatin Calcium Sale Price by Players
      • 3.4 Global Atorvastatin Calcium Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Atorvastatin Calcium Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Atorvastatin Calcium Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Atorvastatin Calcium by Regions

      • 4.1 Atorvastatin Calcium by Regions
        • 4.1.1 Global Atorvastatin Calcium Consumption by Regions
        • 4.1.2 Global Atorvastatin Calcium Value by Regions
      • 4.2 Americas Atorvastatin Calcium Consumption Growth
      • 4.3 APAC Atorvastatin Calcium Consumption Growth
      • 4.4 Europe Atorvastatin Calcium Consumption Growth
      • 4.5 Middle East & Africa Atorvastatin Calcium Consumption Growth

      5 Americas

      • 5.1 Americas Atorvastatin Calcium Consumption by Countries
        • 5.1.1 Americas Atorvastatin Calcium Consumption by Countries (2014-2019)
        • 5.1.2 Americas Atorvastatin Calcium Value by Countries (2014-2019)
      • 5.2 Americas Atorvastatin Calcium Consumption by Type
      • 5.3 Americas Atorvastatin Calcium Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Atorvastatin Calcium Consumption by Countries
        • 6.1.1 APAC Atorvastatin Calcium Consumption by Countries (2014-2019)
        • 6.1.2 APAC Atorvastatin Calcium Value by Countries (2014-2019)
      • 6.2 APAC Atorvastatin Calcium Consumption by Type
      • 6.3 APAC Atorvastatin Calcium Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Atorvastatin Calcium by Countries
        • 7.1.1 Europe Atorvastatin Calcium Consumption by Countries (2014-2019)
        • 7.1.2 Europe Atorvastatin Calcium Value by Countries (2014-2019)
      • 7.2 Europe Atorvastatin Calcium Consumption by Type
      • 7.3 Europe Atorvastatin Calcium Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Atorvastatin Calcium by Countries
        • 8.1.1 Middle East & Africa Atorvastatin Calcium Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Atorvastatin Calcium Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Atorvastatin Calcium Consumption by Type
      • 8.3 Middle East & Africa Atorvastatin Calcium Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Atorvastatin Calcium Distributors
      • 10.3 Atorvastatin Calcium Customer

      11 Global Atorvastatin Calcium Market Forecast

      • 11.1 Global Atorvastatin Calcium Consumption Forecast (2019-2024)
      • 11.2 Global Atorvastatin Calcium Forecast by Regions
        • 11.2.1 Global Atorvastatin Calcium Forecast by Regions (2019-2024)
        • 11.2.2 Global Atorvastatin Calcium Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Atorvastatin Calcium Forecast by Type
      • 11.8 Global Atorvastatin Calcium Forecast by Application

      12 Key Players Analysis

      • 12.1 Pfizer
        • 12.1.1 Company Details
        • 12.1.2 Atorvastatin Calcium Product Offered
        • 12.1.3 Pfizer Atorvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Pfizer News
      • 12.2 DSM Sinochem Pharmaceuticals
        • 12.2.1 Company Details
        • 12.2.2 Atorvastatin Calcium Product Offered
        • 12.2.3 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 DSM Sinochem Pharmaceuticals News
      • 12.3 Cadila Pharmaceuticals
        • 12.3.1 Company Details
        • 12.3.2 Atorvastatin Calcium Product Offered
        • 12.3.3 Cadila Pharmaceuticals Atorvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Cadila Pharmaceuticals News
      • 12.4 Sun Pharmaceutical Industries
        • 12.4.1 Company Details
        • 12.4.2 Atorvastatin Calcium Product Offered
        • 12.4.3 Sun Pharmaceutical Industries Atorvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Sun Pharmaceutical Industries News
      • 12.5 Dr. Reddy’s
        • 12.5.1 Company Details
        • 12.5.2 Atorvastatin Calcium Product Offered
        • 12.5.3 Dr. Reddy’s Atorvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Dr. Reddy’s News
      • 12.6 Morepen
        • 12.6.1 Company Details
        • 12.6.2 Atorvastatin Calcium Product Offered
        • 12.6.3 Morepen Atorvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Morepen News
      • 12.7 Teva Pharmaceutical Industries
        • 12.7.1 Company Details
        • 12.7.2 Atorvastatin Calcium Product Offered
        • 12.7.3 Teva Pharmaceutical Industries Atorvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Teva Pharmaceutical Industries News
      • 12.8 Apotex Pharmachem
        • 12.8.1 Company Details
        • 12.8.2 Atorvastatin Calcium Product Offered
        • 12.8.3 Apotex Pharmachem Atorvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Apotex Pharmachem News
      • 12.9 Sandoz Inc
        • 12.9.1 Company Details
        • 12.9.2 Atorvastatin Calcium Product Offered
        • 12.9.3 Sandoz Inc Atorvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Sandoz Inc News
      • 12.10 Mylan Pharmaceuticals Inc.
        • 12.10.1 Company Details
        • 12.10.2 Atorvastatin Calcium Product Offered
        • 12.10.3 Mylan Pharmaceuticals Inc. Atorvastatin Calcium Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Mylan Pharmaceuticals Inc. News
      • 12.11 Kremers Urban Pharmaceuticals Inc.
      • 12.12 ScieGen Pharmaceuticals, Inc.
      • 12.13 Zheijang Neo-Dankon Pharmaceutical
      • 12.14 Ningbo Menovo Pharmaceuticals Group
      • 12.15 Jialin Pharmaceutical
      • 12.16 Topfond
      • 12.17 Zhejiang Hisun Pharmacutical
      • 12.18 Zhejiang Hongyuan Pharmaceutical
      • 12.19 Hubei Yitai Pharmaceutical
      • 12.20 Jiangsu Hengrui Medicine

      13 Research Findings and Conclusion

      Summary:
      Get latest Market Research Reports on Atorvastatin Calcium . Industry analysis & Market Report on Atorvastatin Calcium is a syndicated market report, published as Global Atorvastatin Calcium Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Atorvastatin Calcium market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,887.74
      4,331.61
      5,775.48
      3,473.34
      5,210.01
      6,946.68
      571,362.60
      857,043.90
      1,142,725.20
      309,160.20
      463,740.30
      618,320.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report